Russia’s Vector State Research Center of Virology and Biotechnology plans to launch production of the novel coronavirus vaccine in November, its Director-General Rinat Maksyutov told Vesti program on Rossiya-1 TV channel.
“We expect to start production already in November this year. So, closer to the end of the year and the start of the next year we can talk about switching to vaccination at least for [people] from risk groups with a further switch to massive vaccination,” Maksyutov said.
Earlier, Russian Deputy Prime Minister Tatyana Golikova told a meeting on the sanitary and epidemiological situation, which was attended by President Vladimir Putin, that the state registration of the COVID-19 vaccine developed by Vector was scheduled for September and the first batch was due to be produced by October.
The spread of the coronavirus infection is declining or stabilizing in 80 Russian regions, Russia’s chief sanitary doctor Anna Popova said in an interview with Vesti program on Rossiya-1 TV channel on Sunday.
“The situation in each region is different, basically today there are 80 regions of the Russian Federation where there is either clear stabilization [of the situation with the disease spread] or decline [in cases]. Only in five regions we observe not very significant and not very evident but unfortunately explained growth,” the head of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing said.